Manchanda, V.; Singh, N. P.; Shamweel, A.; Eideh, H. K.; Thukral, S. S.
July 2006
Indian Journal of Medical Microbiology;Jul2006, Vol. 24 Issue 3, p177
Academic Journal
Purpose: AmpC producing K. pneumoniae have been increasingly reported from India but epidemiological studies are lacking. In the present study, molecular epidemiology of extended-spectrum AmpC beta-lactamases (ESACs) producing clinical isolates of K. pneumoniae prevalent in our hospital was studied. Methods: Fifty-one non-repeat, consecutive, clinical isolates of K. pneumoniae producing AmpC enzymes, were subjected to whole cell protein profile analysis (SDSPAGE) and ribotyping. The antimicrobial susceptibility was determined using standard disk diffusion technique. The isolates showing decreased susceptibility to cefoxitin (<18 mm) or cefotetan (<16 mm) were subjected to modified three-dimensional test for detection of AmpC enzyme. Results: Six different types of protein profiles were observed. Ribotyping could further discriminate between the strains that were clustered by protein fingerprinting. Twelve different ribo-patterns were identified. Ribotyping was found to have a better Discriminatory Index (0.98) than that of SDS-PAGE (0.78). Of the 26 isolates that showed decreased susceptibility to cefoxitin and/or cefotetan 13 isolates were found to harbour AmpC enzyme. Conclusions: The study demonstrated the usefulness of SDS-PAGE whole cell protein profile analysis and ribotyping to identify the clonality of the ESACs isolates, the latter having a higher discriminatory power. The presence of ESACs isolates in the community as well as in hospital settings emphasizes the need for regular monitoring of antimicrobial resistance.


Related Articles

  • Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011. Ubukata, Kimiko; Chiba, Naoko; Morozumi, Miyuki; Iwata, Satoshi; Sunakawa, Keisuke // Journal of Infection & Chemotherapy (Springer Science & Business;Feb2013, Vol. 19 Issue 1, p34 

    In Japan, β-lactamase-nonproducing, ampicillin-resistant organisms have been evident among Haemophilus influenzae type b (Hib) isolates since 2000, when no appropriate vaccine had been approved. We therefore performed molecular analysis of agents causing H. influenzae meningitis nationwide...

  • beta-lactamase. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p97 

    An encyclopedia entry for "beta-lactamase" is presented. It is an enzyme called as lactamase that inactivates antibiotic drugs such as penicillins. Bacteria that have the ability to produce them are resistant to treatment with these kinds of antibiotic drugs.

  • Clinical Role of β-Lactam/β-Lactamase Inhibitor Combinations. Lee, Nelson; Yuen, Kwok-Yung; Kumana, Cyrus R. // Drugs;2003, Vol. 63 Issue 14, p1511 

    The use of β-lactamase inhibitors in combination with β-lactam antibiotics is currently the most successful strategy to combat a specific resistance mechanism. Their broad spectrum of activity originates from the ability of respective inhibitors to inactivate a wide range of...

  • Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. Rogers, Benjamin A.; Sidjabat, Hanna E.; Paterson, David L. // Journal of Antimicrobial Chemotherapy (JAC);Jan2011, Vol. 66 Issue 1, p1 

    Escherichia coli sequence type 131 (ST131) is a worldwide pandemic clone, causing predominantly community-onset antimicrobial-resistant infection. Its pandemic spread was identified in 2008 by utilizing multilocus sequence typing (MLST) of CTX-M-15 extended-spectrum β-lactamase-producing E....

  • Dynamical Aspects of TEM-1 �-Lactamase Probed by Molecular Dynamics. Roccatano, Danilo; Sbardella, Gianluca; Aschi, Massimiliano; Amicosante, Gianfranco; Bossa, Cecilia; Di Nola, Alfredo; Mazza, Fernando // Journal of Computer-Aided Molecular Design;May2005, Vol. 19 Issue 5, p329 

    The dynamical aspects of the fully hydrated TEM-1 �-lactamase have been determined by a 5 ns Molecular Dynamics simulation. Starting from the crystallographic coordinates, the protein shows a relaxation in water with an overall root mean square deviation from the crystal structure...

  • Resistance-gene Analysis of Extended-spectrum β-lactamase-producing Bacteria in Our Clinic. ^Shinoyama, Akihiro; Norose, Yoshihiko; Sonobe, Kazunari; Miura, Yoshihiko; Fujita, Masahisa; Arashiro, Yasuko; Nakamura, Yuzo; Iino, Kouei; Tsunoda, Ryu; Maeda, Miho; Takahashi, Hidemi; Satomura, Katsuaki // Journal of Nippon Medical School;2009, Vol. 76 Issue 6, p326 

    The article presents a study which examines the resistance-gene of extended-spectrum β-lactamase- (ESBLs) bacteria. It states that most of these enzymes cause resistance to aminoglycoside and new quinone antibodies. It mentions that the ESBL resistance genes are transmitted via plasmids...

  • Active-site mutants of class B β-lactamases: substrate binding and mechanistic study. Prosperi-Meys, C.; De Seny, D.; Llabres, G.; Galleni, M.; Lamotte-Brasseur, J. // Cellular & Molecular Life Sciences;Dec2002, Vol. 59 Issue 12, p2136 

    Increased resistance to β-lactam antibiotics is mainly due to β-lactamases. X-ray structures of zinc β-lactamases unraveled the coordination of the metal ions, but their mode of action remains unclear. Recently, enzymes in which one of the zinc ligands was mutated have been...

  • Differential β-lactam resistance response driven by ampD or dacB (PBP4) inactivation in genetically diverse Pseudomonas aeruginosa strains. Zamorano, Laura; Moyá, Bartolomé; Juan, Carlos; Oliver, Antonio // Journal of Antimicrobial Chemotherapy (JAC);Jul2010, Vol. 65 Issue 7, p1540 

    The article discusses a study which examines differential β-lactam resistance response driven by ampD or dacB inactivation in Pseudomonas aeruginosa strains. For the study, researchers analyzed the ampD and dacB knockout mutants of strains PAO1, PA14 and eight genetically untreated...

  • Molecular docking and ligand specificity in fragment-based inhibitor discovery. Yu Chen; Shoichet, Brian K. // Nature Chemical Biology;May2009, Vol. 5 Issue 5, p358 

    Fragment screens have successfully identified new scaffolds in drug discovery, often with relatively high hit rates (5%) using small screening libraries (1,000–10,000 compounds). This raises two questions: would other noteworthy chemotypes be found were one to screen all commercially...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics